Theses/Dissertations from 2015


Immunotherapy for Human Breast Cancer, Al Kamal Ali Nasrah

Theses/Dissertations from 2013


Histone Deacetylation as a Mechanism of YPEL3 Down-Regulation in ER-a Positive Breast Cancer Cell Lines, Remah Ali

Submissions from 2010

Progression and Treatment of HER2-Positive Breast Cancer, April Davoli, Barbara A. Hocevar, and Thomas L. Brown


Incidental Lymphoma during Sentinel Lymph Node Biopsy for Breast Cancer, Justin P. Fox, Valerie P. Grignol, P. Cheng, Roxane Weighall, James R. Ouellette, Minia Hellan, Y. Dowdy, and Paula M. Termuhlen


Montgomery County Breast Cancer Study: Demographic Analysis of Breast Cancer in Montgomery County, Ohio, Danial Jilani

Submissions from 2008

Membrane-Bound (MB) Catechol-O-Methyltransferase (COMT) Genetic Polymorphisms, Catechol Estrogen Conjugation and Breast Cancer Risk Reduction, Y. Ji, James E. Olson, J. Zhang, M. A. Hildebrandt, L. Wang, J. N. Ingle, Z. S. Fredericksen, T. A. Sellers, W. R. Miller, J. M. Dixon, H. Brauch, M. Eichelbaum, C. Justenhoven, U. Hamann, Y. Ko, T. Buening, J. Chang-Claude, S. Wang-Gohrke, D. J. Schaid, and R. M. Weinshilboum

Submissions from 2006


Int7G24A Variant of Transforming Growth Factor-β Receptor Type I is Associated with Invasive Breast Cancer, Taiping Chen, Chad R. Jackson, Andrew Link, Michael P. Markey, Bruce M. Colligan, Larry E. Douglass, Jackson O. Pemberton, James A. Deddens, Jeremy R. Graff, and Julia Carter

Deficiencies in Phenotype Expression and Function of Dentritic Cells from Patients with Early Breast Cancer, C. Kichler-Lakomy, Alexandra C. Budinsky, Roswitha M. Wolfram, Minia Hellan, Chistoph Wiltschke, Thomas Brodowicz, H. Viernstein, and Christoph C. Zielinski

Submissions from 2005

Comparison of Male And Female Breast Cancer Incidence Trends, Tumor Characteristics, And Survival, Teresa D. Hill, Harry J. Khamis, Jerzy E. Tyczynski, and Hans J. Berkel

Breast Cancer Screening for Primary Care Providers, G. Ventolini, J. A. Hall, Margaret M. Dunn, J. M. Duke, and W. W. Hurd

Submissions from 2004

Breast Cancer Size in Postmenopausal Women in Correlation with Body Mass Index and Androgen Serum Levels, E. Asseryanis, E. Ruecklinger, Minia Hellan, E. Kubista, and C. F. Singer

Submissions from 2003

Complementary Therapy in Patients with Early Breast Cancer During Adjuvant Chemotherapy, J. Auerbach, Minia Hellan, M. Stierer, and E. Kubista

Submissions from 2000

Analysis of p43 Positive Lymphocytes from Peripheral Blood for Early Detection of Non Palpable Breast Cancer, L. Auerbach, Minia Hellan, R. C. Alexander, C. Moroz, S. Panzer, R. R. Harald, and E. Kubista


Role of Mammography in Diagnosis of Breast Cancer in an Inner-City Hospital, Akpofure Peter Ekeh, Rebecca S. Alleyne, and Albert O. Duncan


Defective Antigen Presentation Resulting from Impaired Expression of Costimulatory Molecules in Breast Cancer, Roswitha M. Wolfram, Alexandra C. Budinsky, Thomas Brodowicz, Marion Kubista, Wolfgang J. Köstler, Christina Kichler-Lakomy, Minia Hellan, Gerhard Kahlhammer, Chistoph Wiltschke, and Christoph C. Zielinski

Submissions from 1999

Identification of Women with Early Breast Cancer by Analysis of p43-positive Lymphocytes, L. Auerbach, Minia Hellan, M. Stierer, A. C. Rosen, C. Ausch, R. Obwegeser, E. Kubista, G. Wolf, H. R. Rosen, and S. Panzer

Submissions from 1998


Doing Nothing is No Choice: Lay Constructions of Treatment Decision-Making Among Women with Early-stage Breast Cancer, Cathy Charles, Cristina Redko, Tim Whelan, Amiram Gafni, and Leonard Reyno

Submissions from 1996

Preoperative Chemotherapy in Breast Cancer, Margaret M. Dunn

Treatment Decision Making Experiences among Women with Breast Cancer, Cristina Redko, C. Charles, Amiram Gafni, Tim Whelan, and Leonard Reyno

Submissions from 1992

Placental Isoferritin – A Marker for Early Breast Cancer? - First Results of a Multicenter Study, Minia Hellan, L. Auerbach, H. R. Rosen, R. Obwegeser, M. Stierer, A. C. Rosen, G. Wolf, E. Kubista, and S. Panzer

Submissions from 1991

Relation Between p53 Overexpression and Established Prognostic Factors in Breast Cancer, A. M. Davidoff, J. E. Herndon Jr., N. S. Glover, Billie-Jo M. Kerns, Jeffrey C. Pence, James Dirk Iglehart, and J. R. Marks

p53 Alterations in All Stages of Breast Cancer, Andrew M. Davidoff, Billie-Jo M. Kerns, Jeffrey C. Pence, Jeffrey R. Marks, and James Dirk Iglehart

Proliferation Index in Various Stages of Breast Cancer Determined by Ki-67 Immunostaining, Jeffrey C. Pence, Ali M. Kizilbash, Billie-Jo M. Kerns, Jeffrey R. Marks, and James Dirk Iglehart

Submissions from 1990


c-erbB-2 Expression in Breast Cancer Detected by Immunoblotting and Immunohistochemistry, Billie-Jo M. Kerns, Jeffrey C. Pence, Gudrun Huper, Robert Kinney, and James Dirk Iglehart